Literature DB >> 2119263

Significance of initial ST segment elevation and depression for the management of thrombolytic therapy in acute myocardial infarction. European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator.

J L Willems1, R J Willems, G M Willems, A E Arnold, F Van de Werf, M Verstraete.   

Abstract

To determine the ability of initial ST segment elevation and depression to predict infarct size limitation by thrombolytic therapy, data were analyzed in 721 patients with acute myocardial infarction who were admitted to a randomized, placebo-controlled study of intravenous recombinant tissue-type plasminogen activator. Patients with QRS duration of 120 msec or more or with previous history of myocardial infarction were excluded, leaving 322 in the treatment and 333 in the placebo group. Cumulative 72-hour release of alpha-hydroxybutyrate dehydrogenase and global ejection fraction as well as left ventricular wall motion derived from angiography were used as independent measures of infarct size. Electrocardiograms obtained at admission, 6 hours after start of therapy, and before discharge were analyzed. All ST measurements were made by hand at the J point and 60 msec after the J point. Patients with high ST segment elevation at admission (i.e., sum of ST elevation at 60 msec after the J point was 20 mm or more) had significantly larger infarction and higher hospital mortality when compared with those with lower (less than 20 mm) ST elevation. Reciprocal ST segment depression also showed a linear relation with infarct size and mortality, independent from ST elevation, both in anterior and inferior myocardial infarction. The sum of deviations measured at the J point and 60 msec after the J point differed significantly, especially in anterior myocardial infarction at admission (mean, 16 +/- 9 versus 23 +/- 11 mm). The prognostic value of one measurement was not, however, superior over the other. Treatment with recombinant tissue-type plasminogen activator was most effective in those with large ST deviations at admission, but patients with anterior infarction and smaller ST shifts also appeared to benefit from therapy. Results in individual patients were variable, and the overall correlation of initial ST shifts with enzymatic infarct size was rather low. In conclusion, the present study shows that the magnitude of initial ST elevation and also of reciprocal ST depression in the admission electrocardiogram is valuable for the management and assessment of thrombolytic therapy in patients with acute myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2119263     DOI: 10.1161/01.cir.82.4.1147

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  11 in total

1.  ECG monitoring, biochemical Testing, and Anticoagulation Assessment.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

2.  Significance of initial ST segment changes for thrombolytic treatment in first inferior myocardial infarction.

Authors:  K Schröder; K Wegscheider; K L Neuhaus; U Tebbe; R Schröder
Journal:  Heart       Date:  1997-06       Impact factor: 5.994

Review 3.  The electrocardiogram in ST elevation acute myocardial infarction: correlation with coronary anatomy and prognosis.

Authors:  Y Birnbaum; B J Drew
Journal:  Postgrad Med J       Date:  2003-09       Impact factor: 2.401

4.  Clinical Utility of Electrocardiographic ST-Segment Area for Predicting Unsatisfactory Outcomes Following Thrombolytic Therapy.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

5.  Assessment of coronary reperfusion in patients with myocardial infarction using fatty acid binding protein concentrations in plasma.

Authors:  M J de Groot; A M Muijtjens; M L Simoons; W T Hermens; J F Glatz
Journal:  Heart       Date:  2001-03       Impact factor: 5.994

6.  Interpretable Assessment of ST-Segment Deviation in ECG Time Series.

Authors:  Israel Campero Jurado; Andrejs Fedjajevs; Joaquin Vanschoren; Aarnout Brombacher
Journal:  Sensors (Basel)       Date:  2022-06-29       Impact factor: 3.847

7.  Serum Lp(a) lipoprotein concentration and outcome of thrombolytic treatment for myocardial infarction.

Authors:  A D MBewu; P N Durrington; M I Mackness; L Hunt; W H Turkie; J E Creamer
Journal:  Br Heart J       Date:  1994-04

8.  Comparison of different methods of ST segment resolution analysis for prediction of 1-year mortality after primary angioplasty for acute myocardial infarction.

Authors:  Jakub Przyluski; Maciej Karcz; Lukasz Kalińczuk; Mariusz Kruk; Jerzy Pregowski; Edyta Kaczmarska; Joanna Petryka; Paweł Bekta; Tomasz Deptuch; Cezary Kepka; Adam Witkowski; Witold Ruzyllo
Journal:  Ann Noninvasive Electrocardiol       Date:  2007-01       Impact factor: 1.468

9.  New ST-depression: an under-recognized high-risk category of 'complete' ST-resolution after reperfusion therapy.

Authors:  Harvey D White; Cheuk-Kit Wong; Wanzhen Gao; Aaron Lin; Jocelyne Benatar; Philip Eg Aylward; John K French; Ralph A Stewart
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2012-09

10.  EKG Criteria for Fibrinolysis: What's Up with the J Point?

Authors:  Joseph Brownfield; Mel Herbert
Journal:  West J Emerg Med       Date:  2008-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.